@InProceedings{BOOK1,
	author=	{Frederic H. Martini, Robert B. Tallitsch, Judi L. Nath},
	title=	{{Anatomia umana}},
	booktitle=	{{Anatomia umana }},
	year=	{2019},
}

@InProceedings{BOOK2,
	author=	{Luciano Zocchi},
	title=	{{Principi di fisiologia}},
	booktitle=	{{Principi di fisiologia}},
	year=	{2012},
}

@misc{LINFOMIAIL,
	author = {ASSOCIAZIONE ITALIANA CONTRO LEUCEMIE LINFOMI E MIELOMI (AIL)},
	title = {{PATOLOGIE EMATOLOGICHE: LINFOMI}},
	url = {{https://www.ail.it/patologie-e-terapie/patologie-ematologiche/linfomi}},
}

@misc{img1,
	author = {Pharmacy180},
	title = {{Anatomy and Physiology for Health Professionals: Lymphatic System and Immunity
}},
	url = {{https://www.pharmacy180.com/article/lymphatic-system-and-immunity-3637/}},
}

@misc{img2,
	author = {National Cancer Institute },
	title = {{Lymph System}},
	url = {{https://www.cancer.gov/publications/dictionaries/cancer-terms/def/lymph-system}},
}

@misc{LNHAIL,
	author = {ASSOCIAZIONE ITALIANA CONTRO LEUCEMIE LINFOMI E MIELOMI (AIL)},
	title = {{LINFOMA NON HODGKIN}},
	url = {{https://www.ail.it/patologie-e-terapie/patologie-ematologiche/linfomi/576-linfoma-non-hodgkin}},
}

@misc{LNHAIMAC,
	author = {Associazione italiana malati di cancro parenti e amici (AIMAC)},
	title = {{I linfomi non Hodgkin}},
	url = {{https://www.aimac.it/libretti-tumore/linfomi-non-hodgkin/qual-e-la-differenza-tra-linfoma-di-hodgkin-e-linfomi-non-hodgkin#:~:text=Un%20linfoma%20non%20Hodgkin%20si,dei%20linfomi%20del%20secondo%20tipo}},
}

@misc{AMERICANCS,
	author = {The American Cancer Society medical and editorial content team},
	title = {{Non-Hodgkin Lymphoma Causes, Risk
Factors, and Prevention}},
	url = {{https://www.cancer.org/content/dam/CRC/PDF/Public/8718.00.pdf}},
}

@misc{AIOM,
	author = {Associazione Italiana di Oncologia Medica (AIOM)},
	title = {{Linee guida linfomi}},
	url = {{https://www.aiom.it/wp-content/uploads/2018/11/2018_LG_AIOM_Linfomi.pdf}},
}

@misc{AIRTUM,
	author = {Associazione Italiana Registri Tumori (AIRTUM)},
	title = {{Cos'è AIRTUM}},
	url = {{https://www.registri-tumori.it/cms/pagine/cosa-%C3%A9-airtum}},
}

@misc{AIRC,
	author = {Associazione Italiana Ricerca Cancro (AIRC)},
	title = {{Guida ai tumori. Linfoma non-Hodgkin}},
	url = {{https://www.airc.it/cancro/informazioni-tumori/guida-ai-tumori/linfoma-non-hodgkin}},
}

@misc{Americanstatistic,
	author = {American Statistic Center},
	title = {{Non-Hodgkin Lymphoma 2022 Estimates}},
	url = {{https://cancerstatisticscenter.cancer.org/#!/}}
}

@misc{reteveneta,
	author = {Rete Ematologica Veneta},
	title = {{Percorsi Diagnostico Terapeutici Assistenziali (PDTA)
LINFOMI NON HODGKIN}},
	url = {{https://rev.aopd.veneto.it/all/PDTA_Linfomi_Non_Hodgkin.pdf}}
}

@misc{LLS,
	author = {Leukemia and Lymphoma Society},
	title = {{Non-Hodgkin Lymphoma}},
	url = {{https://www.lls.org/sites/default/files/2022-07/PS58_NHL_2022.pdf}}
}

@misc{ISTGENT,
	author = {Gentili Oncology},
	title = {{Linfoma Non Hodgkin}},
	url = {{shorturl.at/fhiM5}}
}

@InProceedings{MIPI,
	author=	{Lim SY,Horsman JM,Hancock BW.},
	title=	{{The Mantle Cell Lymphoma International Prognostic Index: Does it work in routine practice?}},
	booktitle=	{{Oncol Lett.}},
	month=	{Jan},
	year=	{2010},
}

@misc{AMERICANCANCER,
	author = {American Cancer Society},
	title = {{Non-Hodgkin Lymphoma Early
Detection, Diagnosis, and Staging}},
	url = {{https://www.cancer.org/content/dam/CRC/PDF/Public/8719.00.pdf}}
}

@misc{ISS,
	author = {Istituto Superiore di Sanità},
	title = {{Linfoma non Hodgkin (LNH)}},
	url = {{https://www.issalute.it/index.php/la-salute-dalla-a-alla-z-menu/l/linfoma-non-hodgkin#diagnosi}}
}

@misc{img4-6-7,
	author = {Associazione Italiana di Oncologia Medica (AIOM)},
	title = {{I NUMERI
DEL CANCRO
IN ITALIA
2021}},
	url = {{shorturl.at/npvIQ}},
}

@misc{img5,
	author = {Associazione Italiana Registri Tumori},
	title = {{I NUMERI
DEL CANCRO
IN ITALIA
2020}},
	url = {{shorturl.at/oBEQV}},
}

@misc{img15-18,
	author = {Ematologia in Progress},
	title = {{Linfoma non Hodgkin}},
	url = {{https://www.ematologiainprogress.it/linfoma-non-hodgkin/}},
}


@misc{img19,
	author = {Info Medics},
	title = {{Indici prognostici per il Linfoma Follicolare}},
	url = {{https://www.infomedics.it/therapeutic-areas/leucemie-e-linfomi/lnh/linfoma-follicolare/indici-prognostici-linfoma-follicolare.html}},
}

@misc{NIH,
	author = {National Cancer Institute},
	title = {{Radiation Therapy to Treat Cancer}},
	url = {{https://www.cancer.gov/about-cancer/treatment/types/radiation-therapy}}
}

@misc{ACSRADIATION,
	author = {American Cancer Society},
	title = {{Treating Non-Hodgkin Lymphoma}},
	url = {{https://www.cancer.org/content/dam/CRC/PDF/Public/8720.00.pdf}}
}

@misc{MACMILLAN,
	author = {Macmillan Cancer Support},
	title = {{Radiotherapy}},
	url = {{https://www.macmillan.org.uk/cancer-information-and-support/treatment/types-of-treatment/radiotherapy}}
}

@misc{UKRADIOTP,
	author = {Cancer Research UK},
	title = {{Radiotherapy treatment}},
	url = {{https://www.cancerresearchuk.org/about-cancer/non-hodgkin-lymphoma/treatment/radiotherapy/treatment}}
}

@misc{IMMUNOTP,
	author = {American Cancer Society},
	title = {{Immunotherapy}},
	url = {{https://www.cancer.org/content/dam/CRC/PDF/Public/6678.00.pdf}}
}

@misc{LLSIMMUNO,
	author = {Leukemia and Lymphoma Society},
	title = {{Immunotherapy}},
	url = {{https://www.lls.org/sites/default/files/2021-05/FS9_Immunotherapy_Facts2020FINAL.pdf}}
}

@misc{NIHCART,
	author = {National Cancer Institute},
	title = {{CAR T Cells: Engineering Patients’ Immune Cells to Treat Their Cancers}},
	url = {{https://www.cancer.gov/about-cancer/treatment/research/car-t-cells}}
}


@misc{EMATOCART,
	author = {Ematologia In Progress},
	title = {{Cellule CAR-T}},
	url = {{https://www.ematologiainprogress.it/cellule-car-t/}}
}

@misc{LLSCART,
	author = {Leukemia and Lymphoma Society},
	title = {{Chimeric Antigen Receptor (CAR) T-Cell Therapy}},
	url = {{https://www.lls.org/sites/default/files/2022-07/FS27_CART_rev_7_22.pdf}}
}

@misc{AILCENTRI,
	author = {Associazione Italiana contro Leucemie Linfomi e Mielomi (AIL)},
	title = {{I centri autorizzati alla somministrazione delle terapie CAR-T}},
	url = {{https://www.ail.it/patologie-e-terapie/terapie/car-t/l-accesso-alle-car-t/centri-autorizzati}}
}


@InProceedings{Frontiers,
	author=	{Miao L, Zhang Z, Ren Z and
Li Y},
	title=	{{ Reactions Related
to CAR-T Cell Therapy}},
	booktitle=	{{ Front Immunol}},
	month=	{April},
	year=	{2021},
}


@InProceedings{Cortico,
  author =  {Liu S,Deng B,Yin Z et al.},
  title =  {{ Corticosteroids do not influence the efficacy and kinetics of CAR-T cells for B-cell acute lymphoblastic leukemia}},
  booktitle =  {{ Blood cancer journal}},
  month =  {Feb},
  year =  {2020},
}

@InProceedings{ASTCT,
	author=	{Lee DW,Santomasso BD,Locke FL et al.},
	title=	{{ ASTCT Consensus Grading for Cytokine Release Syndrome and Neurologic Toxicity Associated with Immune Effector Cells}},
	booktitle=	{{ Biol Blood Marrow Transplant}},
	month=	{April},
	year=	{2019},
}


@misc{MASSIVEBIO,
	author = {Massive Bio},
	title = {{Immunotherapy for Non-Hodgkin Lymphoma}},
	url = {{https://massivebio.com/immunotherapy-for-lymphoma/}}
}

@misc{LOWGRADE,
	author = {Lymphoma Action},
	title = {{Low-grade non-Hodgkin lymphoma}},
	url = {{shorturl.at/astz2}}
}

@misc{BORTNURSES,
	author = {Myeloma Special Practice Network(M-SPN)},
	title = {{BORTEZOMIB
BEST PRACTICE
A guide for nurses}},
	url = {{shorturl.at/aclM0}}
}

@article{img28,
author = {Knop, Carol and Milliron, Todd},
year = {2012},
month = {11},
pages = {406-10},
title = {Subcutaneous Administration of Bortezomib: Strategies to Reduce Injection Site Reactions},
volume = {3},
journal = {Journal of the advanced practitioner in oncology},
doi = {10.6004/jadpro.2012.3.6.8}
}

@article{BORTEZOMIB,
  title={Subcutaneous Administration of Bortezomib: Strategies to Reduce Injection Site Reactions},
  author={Sandra E. Kurtin and Carol Knop and Todd Milliron},
  journal={Journal of the advanced practitioner in oncology},
  year={2012},
  volume={3},
  pages={406 - 410}
}

@misc{TRAPIANTO,
	author = {Unità Operativa e Centro Trapianti di Midollo
Osseo “Wilma Deplano”.
Ospedale Oncologico “Armando Businco”
Cagliari},
	title = {{IL TRAPIANTO DI MIDOLLO OSSEO
O DI CELLULE STAMINALI
EMOPOIETICHE PERIFERICHE
Guida informativa per i pazienti}},
	url = {{shorturl.at/bdMU0}}
}

@misc{STEMCELLS,
	author = {American Cancer Society},
	title = {{Stem Cell or Bone Marrow Transplant}},
	url = {{https://www.cancer.org/content/dam/CRC/PDF/Public/128.00.pdf}}
}

@misc{LLSBLOOD,
	author = {Leukemia and Lymphoma Society},
	title = {{Blood and Marrow
Stem Cell
Transplantation
Guide}},
	url = {{https://www.lls.org/sites/default/files/2021-05/PS40_BloodMarrow_2018.pdf}}
}

@misc{img35,
	author = {Fondazione Italiana Linfomi (FIL)},
	title = {{Transplantation}},
	url = {{https://filinf.it/en/about-limphomas/transplantation/}},
}

@InProceedings{TRANS,
	author=	{Li C,Zhang Y,Zhang C et al.},
	title=	{{ Comparation of CART19 and autologous stem-cell transplantation for refractory/relapsed non-Hodgkin's lymphoma.}},
	booktitle=	{{ JCI Insight.}},
	month=	{July},
	year=	{2019},
}


@InProceedings{GVHD,
	author=	{Martin PJ,Rizzo JD,Wingard JR et al.},
	title=	{{ First- and second-line systemic treatment of acute graft-versus-host disease: recommendations of the American Society of Blood and Marrow Transplantation.}},
	booktitle=	{{ Biol Blood Marrow Transplant.}},
	month=	{April},
	year=	{2012},
}

@misc{img38,
	author = {National Marrow Donor Program},
	title = {{GVHD signs and symptoms}},
	url = {{https://bethematch.org/patients-and-families/life-after-transplant/physical-health-and-recovery/gvhd-signs-and-symptoms/}},
}

@misc{CHEMOUK,
	author = {Cancer Research UK},
	title = {{Chemotherapy treatment}},
	url = {{https://www.cancerresearchuk.org/about-cancer/non-hodgkin-lymphoma/treatment/chemotherapy/about}}
}

@misc{CHEMOAMERICAN,
	author = {American Cancer Society},
	title = {{How Is Chemotherapy Used to Treat
Cancer?}},
	url = {{https://www.cancer.org/content/dam/CRC/PDF/Public/8417.00.pdf}}
}

@misc{LYMPHACTION,
	author = {Lymphoma Action},
	title = {{Chemotherapy}},
	url = {{shorturl.at/evTXY}}
}

@misc{CNS,
	author = {Lymphoma Action},
	title = {{CNS prophylaxis}},
	url = {{shorturl.at/bfJ79}}
}

@misc{img39,
	author = {CURE SEARCH},
	title = {{Lumbar Puncture (Spinal Tap)}},
	url = {{https://curesearch.org/Lumbar-Puncture}},
}

@misc{HIGHGRADE,
	author = {Lymphoma Action},
	title = {{High-grade
non-Hodgkin
lymphoma}},
	url = {{shorturl.at/lO069}}
}

@misc{AIOMTOSS,
	author = {Associazione Italiana di Oncologia Medica (AIOM)},
	title = {Linee guida GESTIONE DELLA TOSSICIT\'A EMATOPOIETICA IN ONCOLOGIA}},
	url = {{shorturl.at/dADFU}}
}

@misc{LLSLOWCELLS,
	author = {Leukemia and Lymphoma Society},
	title = {SIDE-EFFECT MANAGEMENT: Managing Low Blood Cell Counts}},
	url = {{shorturl.at/glILV}}
}

@misc{AMERICANLOWCELLS,
	author = {American Cancer Society},
	title = {Low Red Blood Cell Counts (Anemia)}},
	url = {{https://www.cancer.org/content/dam/CRC/PDF/Public/7529.pdf}}
}

@misc{AMERICANPLATELET,
	author = {American Cancer Society},
	title = {Low Platelet Count (Bleeding)}},
	url = {{https://www.cancer.org/content/dam/CRC/PDF/Public/8900.00.pdf}}
}

@misc{AMERICANFERTILITY,
	author = {American Cancer Society},
	title = {How Cancer And Cancer Treatment Can
Affect Fertility}},
	url = {{https://www.cancer.org/content/dam/CRC/PDF/Public/9255.00.pdf}}
}

@misc{UKFERTILITY,
	author = {Cancer Research UK},
	title = {Sex and fertility}},
	url = {{https://www.cancerresearchuk.org/about-cancer/non-hodgkin-lymphoma/living-with/sex-fertility}}
}

@misc{ISSESPO,
	author = {ISTITUTO SUPERIORE DI SANITÀ},
	title = {Esposizione professionale
a chemioterapici antiblastici:
rischi per la riproduzione
e strategie per la prevenzione}},
	url = {{shorturl.at/beKLP}}
}

@misc{FNOPI,
	author = {MINISTERO DELLA SANITÀ DIPARTIMENTO DELLA PREVENZIONE COMMISSIONE ONCOLOGICA NAZIONALE},
	title = {Linee guida per la sicurezza e la salute dei lavoratori esposti a chemioterapici antiblastici in ambiente sanitario}},
	url = {{https://www.fnopi.it/wp-content/uploads/PROV050899.pdf}}
}

@misc{GAVECELTCVC,
	author = {GAVeCeLT Gli Accessi Venosi Centrali a Lungo Termine},
	title = {Cateteri	Midline	vs.	altri	accessi	
venosi	periferici	nella	terapia	
endovenosa	}},
	url = {{https://gavecelt.it/nuovo/sites/default/files/uploads/Gli-accessi-venosi-periferici-oggi.pdf}}
}

@misc{GAVECELTracc2021,
	author = {GAVeCeLT Gli Accessi Venosi Centrali a Lungo Termine},
	title = {RACCOMANDAZIONI GAVeCeLT 2021
PER LA INDICAZIONE, L’IMPIANTO E LA GESTIONE
DEI DISPOSITIVI PER ACCESSO VENOSO}},
	url = {{shorturl.at/nopBP}}
}

@misc{img40,
	author = {Azienda Ospedaliera
Ospedali Riuniti Marche Nord},
	title = {{Posizionamento Picc e Midline}},
	url = {{https://www.ospedalimarchenord.it/percorsi-di-cura/posizionamento-picc-e-midline/}},
}

@misc{img41,
	author = {Blausen.com staff (2014)},
	title = {{"Medical gallery of Blausen Medical 2014"}},
	url = {{https://en.wikipedia.org/wiki/Central_venous_catheter}},
}

@misc{img42,
	author = {National Cancer Institute},
	title = {{Port-a-cath}},
	url = {{https://www.cancer.gov/publications/dictionaries/cancer-terms/def/port-a-cath}},
}

@misc{AIOMCVC,
	author = {Associazione Italiana di Oncologia Medica (AIOM)},
	title = {Working Group Nursing
Gestione infermieristica
degli accessi vascolari centrali a medio e lungo termine
nel paziente oncologico}},
	url = {{shorturl.at/jvMU5}}
}


@InProceedings{img43,
	author=	{Guiffant, Gérard et al.},
	title=	{{Flushing ports of totally implantable venous access devices, and impact of the Huber point needle bevel orientation: experimental tests and numerical computation.}},
	booktitle=	{{ Med Devices (Auckl)}},
	month=	{April},
	year=	{2012},
}

@misc{img44,
	author = {LIFC Lazio Comitato OFFICIUM},
	title = {{Port-a-cath
Gestione
domiciliare}},
	url = {{https://www.officiumroma.it/wp-content/uploads/2017/09/tre-ante-porth.pdf}},
}

@misc{img45,
	author = {Centro di Riferimento Oncologico di Aviano (CRO)},
	title = {{GESTIONE INFERMIERISTICA DEL
PORT}},
	url = {{https://www.burlo.trieste.it/sites/default/files/slides-corsi/presentazione_su_Port-a-Cath.pdf}},
}

@misc{img46,
	author = {NURSE TIMES},
	title = {{Cateteri Venosi Centrali e sistema needle-free connectors (NFC). Pills}},
	url = {{https://nursetimes.org/cateteri-venosi-centrali-e-sistema-needle-free-connectors-nfc-pills/55254}},
}

@misc{img47,
	author = {GAVeCeLT Gli Accessi Venosi Centrali a Lungo Termine},
	title = {{Curos Disinfecting Port Protectors}},
	url = {{http://gavecelt.it/nuovo/sites/default/files/uploads/Uso%20dei%20port%20protectors%20-%20Curos.pdf}},
}

@misc{CRO,
	author = {Centro di Riferimento Oncologico di Aviano (CRO)},
	title = {Il PICC-PORT
Guida per il paziente}},
	url = {{https://www.cro.it/export/sites/cro/it/biblioteca/croinforma/pubblicazioni/PICC-PORTpazienti.pdf}}
}

@misc{GAVECELTPICCPORT,
	author = {GAVeCeLT Gli Accessi Venosi Centrali a Lungo Termine},
	title = {Il ruolo futuro dei Picc-Port
in Oncologia}},
	url = {{shorturl.at/FMPTW}}
}

@InProceedings{MERLICCO,
	author=	{Merlicco D, Lombardi M, Fino MC.},
	title=	{{PICC-PORT: Valid indication to placement in patient with results of extensive skin burns of the neck and chest in oncology. The first case in the scientific literature.}},
	booktitle=	{{ Int J Surg Case Rep.}},
	month=	{February},
	year=	{2020},
}

@article{MERLICCO202063,
title = {PICC-PORT: Valid indication to placement in patient with results of extensive skin burns of the neck and chest in oncology. The first case in the scientific literature},
journal = {International Journal of Surgery Case Reports},
volume = {68},
pages = {63-66},
year = {2020},
issn = {2210-2612},
doi = {https://doi.org/10.1016/j.ijscr.2020.02.028},
url = {https://www.sciencedirect.com/science/article/pii/S2210261220301024},
}

@misc{img49,
	author = {Xunta de Galicia},
	title = {{Types and characteristics of PICCs}},
	url = {{https://femora.sergas.es/Coidados-das-vias-sondas-e-drenaxes/Tipos-?idioma=es&print=1}},
}


@misc{img51,
	author = {ISTITUTO ORTOPEDICO RIZZOLI
SSD Reparto di
CHEMIOTERAPIA DEI TUMORI DELL’APPARATO LOCOMOTORE},
	title = {{C.V.C. BROVIAC-HICKMAN}},
	url = {{https://www.associazionemariocampanacci.it/wp-content/uploads/2019/01/Opuscolo-BROVIAC-7-2018-1.pdf}},
}

@misc{FNOPIRIVISTA,
	author = {Fabio Mozzarelli, Valentina Ferrari},
	title = {LE FLEBITI CORRELATE AI CVP: UTILIZZO DELLA VISUAL INFUSION PHLEBITIS SCORE PER UN’EFFICACE PREVENZIONE-FNOPI L'INFERMIERE}},
	url = {{https://www.infermiereonline.org/2018/10/12/le-flebiti-correlate-ai-cvp-utilizzo-della-visual-infusion-phlebitis-score-per-unefficace-prevenzione/}}
}

@InProceedings{img52,
	author=	{Gallant P, Schultz AA.},
	title=	{{Evaluation of a visual infusion phlebitis scale for determining appropriate discontinuation of peripheral intravenous catheters.}},
	booktitle=	{{J Infus Nurs}},
	month=	{Nov-Dec},
	year=	{2006},
}


@misc{img53,
	author = {Andrea Zanasi
U.O. Medicina Interna, Ospedale di Sassuolo},
	title = {{La gestione degli accessi vascolari:
Prevenzione, riconoscimento e gestione delle
complicanze precoci e tardive }},
	url = {{https://ospedalesassuolo.it/wp-content/uploads/2012/11/Prevenzione-riconoscimento-e-gestione-delle-complicanze-Zanasi.pdf}},
}

@misc{img54-55,
	author = {NURSE TIMES},
	title = {{Lo stravaso dei farmaci chemioterapici: istruzioni per il trattamento}},
	url = {{https://nursetimes.org/lo-stravaso-dei-farmaci-chemioterapici-istruzioni-trattamento/40722}},
}


@misc{img56-57,
	author = {M.Dolores Palmas, Infermiera S.C. Oncologia Medica DH
P.O. A. Businco},
	title = {{Il trattamento degli stravasi
dei farmaci citotossici}},
	url = {{http://www.aslcagliari.it/documenti/8_136_20100615160800.pdf}},
}


@misc{EMODIAL,
	author = {EMODIAL},
	title = {LA GESTIONE DELLE MARSI
(Medical Adhesive Related Skin Injuries)}},
	url = {{shorturl.at/ruxU2}}
}

@article{img58,
author = {Mcnichol, Laurie and Lund, Carolyn and Rosen, Ted and Gray, Mikel},
year = {2013},
month = {06},
pages = {267-281},
title = {Medical Adhesives and Patient Safety: State of the Science Consensus Statements for the Assessment, Prevention, and Treatment of Adhesive-Related Skin Injuries},
volume = {32},
journal = {Orthopaedic nursing / National Association of Orthopaedic Nurses},
doi = {10.1097/NOR.0b013e3182a39caf}
}


@misc{DIETA,
	author = {Regione Siciliana
AZIENDA OSPEDALIERA di rilievo nazionale e di alta specializzazione
ARNAS – GARIBALDI di Catania
U.O.C. di Ematologia
(Unità Accreditata ISO 9001:2008 per la gestione della terapia antitumorale)},
	title = {La Dieta nel Paziente Ematologico
”Una guida per i malati e per i loro familiari”}},
	url = {{http://www.ao-garibaldi.ct.it/ematologia/per-i-medici/pdf/la-dieta-nel-paziente-ematologico.pdf}}
}

@misc{LLSNUTRITION,
	author = {Leukemia and Lymphoma Society},
	title = {Food and Nutrition Facts}},
	url = {{shorturl.at/fiqtN}}
}

@misc{LINEEGUIDA,
	author = {Regione Emilia-Romagna. Servizio Sanitario Regionale Emilia-Romagna},
	title = {Linee di indirizzo regionali
sulla buona pratica di cura
degli accessi vascolari}},
	url = {{shorturl.at/EPS49}}
}

@misc{STRAVASOTOSCANA,
	author = {SERVIZIO SANITARIO DELLA TOSCANA, AZIENDA USL TOSCANA CENTRO. DIPARTIMENTO ONCOLOGICO},
	title = {Protocollo clinico assistenziale
Prevenzione e trattamento dello
stravaso da farmaci antiblastici }},
	url = {{https://areariservata.uslcentro.toscana.it/index.php/documenti-usl-tc/area-sanitaria/dipartimento-oncologico/1347-pc-donc-01-prevenzione-e-trattamento-dello-stravaso-da-farmaci-antiblastici/file}}
}

@misc{COMUNICAZIONE,
	author = {Dott.ssa Monica Cardellicchio},
	title = {La comunicazione tra infermiere e paziente.}},
	url = {{https://www.assocarenews.it/infermieri/la-comunicazione-tra-infermiere-e-paziente}}
}

@misc{NURSE24,
	author = {Carla Gatto, Nurse24},
	title = {L'occhio dell'Infermiere e la comunicazione con il paziente}},
	url = {{https://www.nurse24.it/infermiere/infermiere-comunicazione-paziente.html}}
}

@misc{ISOLAMENTO,
	author = {SISTEMA SOCIO SANITARIO REGIONE LOMBARDIA},
	title = {Policy aziendale per l’isolamento del paziente in Ospedale }},
	url = {{https://www.anmdo.org/wp-content/uploads/2020/09/Procedura-isolamento-2016.pdf}}
}

@misc{ALOPECIA,
	author = {REDAZIONE NURSE24},
	title = {Alopecia in chemioterapia, la prevenzione è possibile}},
	url = {{https://www.nurse24.it/infermiere/testimonianze-infermieri/alopecia-in-chemioterapia-prevenzione-possibile.html}}
}

@misc{HAIRLOSS,
	author = {American Cancer Society},
	title = {Cooling Caps (Scalp Hypothermia) to
Reduce Hair Loss}},
	url = {{https://www.cancer.org/content/dam/CRC/PDF/Public/8233.00.pdf}}
}

@misc{HAIRLOSS2,
	author = {American Cancer Society},
	title = {Coping With Hair Loss}},
	url = {{https://www.cancer.org/content/dam/CRC/PDF/Public/8894.00.pdf}}
}

@misc{effetticollaterali,
	author = {Daniela Berardinelli, Nurse24},
	title = {Chemioterapia ed effetti collaterali}},
	url = {{https://www.nurse24.it/infermiere/farmaci/chemioterapia-effetti-collaterali.html}}
}

@misc{mucositi,
	author = {Giuseppe Caldarelli, Nurse24},
	title = {Mucosite del cavo orale nelle neoplasie, come gestirla?}},
	url = {{https://www.nurse24.it/studenti/mucosite-del-cavo-orale-nelle-neoplasie-come-gestirla.html}}
}

@misc{SCALEmucositi,
	author = {D. Musio, M. Trignani},
	title = {TOSSICIT\'A NEI TRATTAMENTI TESTA-COLLO 
    MUCOSITE ORALE}},
	url = {{https://www.congressiairo.it/2017/roma/09.30_Musio-Trignani.pdf}}
}


@misc{img47BIS,
	author = {Vygon Value Life},
	title = {{Scrub the hub versus disinfecting port protectors; the benefits of change}},
	url = {{https://vygon.co.uk/scrub-the-hub-versus-disinfecting-port-protectors-the-benefits-of-change/}},
}
